Study the Feasibility of Permanent Use of inControl for the Treatment of Type 1 Diabetes

NCT02892604 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped not enough participants

Conditions

Type 1 Diabetes

Interventions

DEVICE: insulin pump to inControl AP platform

Sponsor

University Hospital, Montpellier

Collaborators

[object Object]
[object Object]
[object Object]